AML Resources

expand_less

Childhood AML

Here you will find articles that discuss how children ages 0-18 can live their best life with an AML diagnosis and beyond. Each of these articles aim to empower children and their families to live healthfully and navigate an AML diagnosis. AML changes the way kids feel, eat, sleep and think. The articles here will help caregivers navigate these changes and provide you with information on how to overcome them. You will also find topics on living life after AML treatment such as returning to school, emotional support and tips for living as a childhood leukemia survivor.

Additionally, you will be kept up to date on the latest advances in AML that are specifically relevant to children who are 0-18 years old. You will learn about the latest FDA approvals for new drugs and treatment combinations that are indicated for childhood AML. You will also learn about newly published AML research studies and any advances or findings that may contribute to your child's AML treatment.

Vyxeos Now FDA Approved for Children With Secondary AML

Childhood AML—May 19, 2021

The Food and Drug Administration (FDA) approves expanded use for Vyxeos (daunorubicin and cytarabine) that now includes the ability to treat newly diagnosed therapy-related childhood AML.

New Study Finds Higher Likelihood of AML in Children With Down Syndrome

Childhood AML—May 10, 2021

A new study published in the March issue of The Journal of Pediatrics found that children with Down Syndrome have an estimated 150-fold higher risk of developing AML before the age of five.